Cellectis (CLLS) Other Non Operating Income (2021 - 2025)
Cellectis (CLLS) recorded quarterly Other Non Operating Income of -$283000.0 in Q3 2025, down 198.61% quarter-over-quarter from $287000.0 in Q2 2025, and down 176.49% on a YoY basis from $370000.0 in Q3 2024.
Cellectis (CLLS) Other Non Operating Income (2021 - 2025) Analysis & Trends
Cellectis' Other Non Operating Income history runs 5 years deep, the most recent figure standing at -$283000.0 for Q3 2025.
- In Q3 2025, Other Non Operating Income fell 176.49% year-over-year to -$283000.0; the TTM figure through Sep 2025 stood at $1.1 million (up 170.19% YoY), while the FY2021 annual figure was $1.5 million, changed N/A from the prior year.
- Other Non Operating Income was -$283000.0 for Q3 2025 at Cellectis, down from $287000.0 in the prior quarter.
- In the past five years, Other Non Operating Income ranged from a high of $12.9 million in Q3 2021 to a low of -$15.0 million in Q2 2021.
- Historically, Other Non Operating Income has averaged $132625.0 across 5 years, with a median of $62500.0 in 2023.
- The sharpest annual moves came in 2022 and 2025: Other Non Operating Income slumped 189.36% in 2022, then jumped 856.67% in 2025.
- A 5-year view of Other Non Operating Income shows it stood at $3.5 million in 2021, then sank by 105.97% to -$210000.0 in 2022, then surged by 177.14% to $162000.0 in 2023, then jumped by 128.4% to $370000.0 in 2024, then slumped by 176.49% to -$283000.0 in 2025.
- The last three Other Non Operating Income figures came in at -$283000.0 (Q3 2025), $287000.0 (Q2 2025), and $750000.0 (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Cellectis | 17.40 Bn | 17.21 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -283,000.00 |
| Jun 30, 2025 | 287,000.00 |
| Mar 31, 2025 | 750,000.00 |
| Sep 30, 2024 | 370,000.00 |
| Jun 30, 2024 | 30,000.00 |
| Mar 31, 2024 | -146,000.00 |
| Sep 30, 2023 | 162,000.00 |
| Jun 30, 2023 | 95,000.00 |
| Mar 31, 2023 | -80,000.00 |
| Sep 30, 2022 | -210,000.00 |
| Jun 30, 2022 | -255,000.00 |
| Mar 31, 2022 | -126,000.00 |
| Dec 31, 2021 | 3.52 Mn |
| Sep 30, 2021 | 12.92 Mn |
| Jun 30, 2021 | -15.05 Mn |
| Mar 31, 2021 | 141,000.00 |